|A recent study published in the British Medical Journal confirms that patients taking Avandia are 23% more likely to suffer congestive heart failure than those on other medications.Avandia (rosiglitazone) is a diabetes drug which helps to control blood sugar levels in the body. It is prescribed for patients with type 2 diabetes. There have been various studies in recent years which have differed about whether it raises the dangers of heart disease or death.The study of 810,000 diabetes patients, 429,000 of which were on Avandia, and 381,00 on another diabetes drug Actos (pioglitazone), also indicated that Avandia users were 16% more likely to suffer heart attacks and 14% more likely to die while on Avandia. These percentages translate into a possible 431 additional deaths, 170 heart attacks and 649 extra cases of heart failure per every 100,000 of Avandia users.
Last September the European Medicines Agency (EMA) suspended the licence for the drug, after 10 years on the market, saying the evidence of its adverse effects outweighed the benefits of it being prescribed. Due to growing concerns, U.S. health officials last September restricted the use of Avandia to patients with type 2 diabetes who cannot control their disease on other medications. This new study seems to lend more evidence to those concerns and restrictions.
If you or someone you love believe that your heart problems may have been caused by Avandia, please contact our office for a free consultation to determine the best options available to you under the law.